Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

58.1100 USD 1.0400 1.76%

As of 20:04:03 ET on 04/24/2015.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 58.8900 High - Low: 58.9100 - 58.1100 Primary Exchange: NYSE Arca
Volume: 37,767 52-Week Range: 37.5500 - 59.9800 Beta vs DZOTR: 1.0032

ETF Chart for PBE

No chart data available.
  • PBE:US 58.1100
  • 1D
  • 1M
  • 1Y
59.1500
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD / MICHAEL JEANETTE
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2015-04-24) 58.1245
Assets (M) (on 2015-04-24) 563.8077
Shares out (M) 9.70
Market Cap (M) 563.67
% Premium -0.02
Average 52-Week % Premium 0.0012
Fund Leveraged N

Dividends for PBE

Dividend Type Omitted
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.48%

Performance for PBE

1-Month +1.73% 1-Year +46.07%
3-Month +9.00% 3-Year +39.15%
Year To Date +15.76% 5-Year +24.18%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 04/24/2015
Name Position Value % of Total
Pharmacyclics Inc 122,603 31,458,704 5.581%
Regeneron Pharmaceuticals Inc 63,971 30,711,837 5.448%
BioMarin Pharmaceutical Inc 247,255 29,739,831 5.276%
Vertex Pharmaceuticals Inc 221,666 29,525,911 5.238%
Amgen Inc 167,852 28,184,029 5.000%
Gilead Sciences Inc 255,709 26,515,745 4.704%
Alexion Pharmaceuticals Inc 146,774 26,431,062 4.689%
Dyax Corp 955,667 26,223,502 4.652%
Biogen Inc 64,634 25,964,124 4.606%
Repligen Corp 561,654 19,517,477 3.462%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil